Experiment 67096

Details

PropertyValue
Pharmacology
Administration routeORAL
OrganismSalix alba (SALICACEAE)
CitationWAGNER,I: BIEGERT,C: SCHMID,B: HEIDE,L:. (2000). WILLOW BARK IN THE TREATMENT OF RHEUMATIC DISORDERS:RANDOMIZED CLINICAL TRIALS.. 7(2)
Amount utilized
Compound isolated
Disease6-WEEK, PLACEBO-CONTROLLED PILOT TRIAL IN OUTPATIENTS WITH RHEUMATOID ARTHRITIS:THIS PARALLEL TRIAL IS IN PREPARATION IN ORDER TO EVALUATE THE ANALGESIC AND ANTI-INFLAMMATORY EFFICACY OF WILLOW BARK IN RHEUMATOID ARTHRITIS OVER A 6-WEEK TREATMENT PERIOD. OUTCOME MEASURES ARE IN ACCORDANCE WITH THE WHO/ILAR CORE SET OF END-POINTS WITH A PAIN VAS AS PRIMARY OUTCOME VARIABLE. RESULTS OF THE FIRST STUDY AND STUDY PROTOCOLS FOR THE TWO SUBSEQUENT STUDIES WILL BE PRESENTED.
Dose amount240.0 MG
Number3
Qualitative resultACTIVE
AnimalHUMAN ADULT
Per unitDAY
Dose expressionDOSE
ExtractTYPE EXT NOT STATED
GenderGIVEN TO BOTH SEXES